The groundbreaking therapy of this peptide represents a major advance in the management of diabetes mellitus type 2. Distinct from existing medications, tirzepatide targets dual pathways – glucagon-like peptide-1 https://tirzepatidepeptide696464.vidublog.com/40717249/tirzepatide-peptide-a-new-frontier-in-diabetes-treatment